This viewpoint article on a forecast of clinically meaningful changes in the management of
systemic lupus erythematosus (SLE) in the next 10 years is based on a review of the current …

Patient-reported outcome (PRO) instruments are widely used to assess quality of life in
Systemic Lupus Erythematosus (SLE) research, and there is growing evidence for their use …

Background Fatigue is reported as the most prevalent symptom by patients with systemic
lupus erythematosus (SLE). Fatigue management is complex due to its multifactorial nature …

Background Flares in patients with SLE, regardless of their severity, have been associated
with damage accrual. However, their impact on health-related quality of life (HRQoL) has not …

Objective The British Isles Lupus Assessment Group–based Composite Lupus Assessment
(BICLA) is a validated global measure of treatment response in systemic lupus …

Objective To compare physician and patient assessments of global disease activity in anti-
neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) and to identify …

Objective To account for heterogeneity in systemic lupus erythematosus (SLE) and bridge
discrepancies between patient-and physician-perceived SLE activity, we developed the …

Objective The Lupus Foundation of America Rapid Evaluation of Activity in Lupus (LFA-
REAL) system is a novel and simple SLE disease activity instrument, consisting of a tandem …

Objective The Type 1 and 2 systemic lupus erythematosus (SLE) Model was developed to
encapsulate all signs and symptoms that patients with SLE experience. Our previous …

Objective In this pilot study, we used untargeted metabolomics to identify biochemical
mechanisms or biomarkers potentially underlying SLE-related fatigue. Methods Metabolon …